GOLDEN RULES FOR TRADING

Pharma Stocks Outlook for the week – 15 to 19.06.2015 (Seen negative bias next week)

Pharma Stocks Outlook for the week – 15 to 19.06.2015
(Seen negative bias next week)

Even as a negative bias towards shares of pharmaceutical companies is seen continuing next week due to correction, shares of mid-cap drug makers are likely to perform better than their blue-chip peers.

During this week a good correction was seen in the pharma stocks, which is expected to continue going ahead also. Outlook is weak for both the medium term and the short term. Despite the correction in the sector, lesser weakness was witnessed in the mid-cap stocks compared to their blue-chip counterparts, and due to this, the former would outperform the latter next week.

Stocks of Hyderabad-based Aurobindo Pharma Ltd and Mumbai-based Glenmark Pharmaceuticals Ltd were seen outperforming the sector during the next week. He has a negative outlook of larger companies such as Cipla Ltd, Lupin Ltd and Sun Pharmaceutical Industries Ltd.